Barclays PLC Esperion Therapeutics, Inc. Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 155,162 shares of ESPR stock, worth $330,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,162

Previous 104,484 48.5%

Holding current value

$330,495

Previous $280,000 22.86%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $93,247 - $164,196	50,678 Added 48.5%	155,162 $344,000
Q1 2024 May 15, 2024	SELL	$2.02 - $3.02 $33,532 - $50,132	-16,600 Reduced 13.71%	104,484 $280,000
Q4 2023 Feb 15, 2024	BUY	$0.73 - $3.08 $23,433 - $98,868	32,100 Added 36.07%	121,084 $362,000
Q3 2023 Nov 07, 2023	SELL	$0.96 - $1.79 $14,077 - $26,248	-14,664 Reduced 14.15%	88,984 $87,000
Q2 2023 Aug 03, 2023	SELL	$1.2 - $1.76 $68,134 - $99,931	-56,779 Reduced 35.39%	103,648 $144,000
Q1 2023 May 04, 2023	SELL	$1.46 - $7.3 $3,787 - $18,936	-2,594 Reduced 1.59%	160,427 $255,000
Q4 2022 Feb 13, 2023	BUY	$5.09 - $8.5 $617,544 - $1.03 Million	121,325 Added 290.98%	163,021 $1.02 Million
Q3 2022 Nov 03, 2022	BUY	$5.45 - $8.13 $74,212 - $110,706	13,617 Added 48.5%	41,696 $280,000
Q2 2022 Aug 12, 2022	SELL	$4.77 - $6.67 $33,308 - $46,576	-6,983 Reduced 19.92%	28,079 $178,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $202,524 - $337,136	-60,636 Reduced 63.36%	35,062 $163,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $226,512 - $561,336	47,092 Added 96.89%	95,698 $480,000
Q3 2021 Nov 09, 2021	BUY	$11.34 - $21.37 $162,162 - $305,591	14,300 Added 41.68%	48,606 $585,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $28.71 $72,051 - $106,628	-3,714 Reduced 9.77%	34,306 $726,000
Q1 2021 May 13, 2021	SELL	$25.12 - $36.89 $442,237 - $649,448	-17,605 Reduced 31.65%	38,020 $1.07 Million
Q4 2020 Feb 11, 2021	BUY	$24.2 - $35.76 $1.06 Million - $1.57 Million	43,764 Added 368.97%	55,625 $1.45 Million
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $5.4 Million - $9.14 Million	-173,332 Reduced 93.6%	11,861 $441,000
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $179,789 - $307,090	5,985 Added 3.34%	185,193 $9.5 Million
Q1 2020 May 13, 2020	BUY	$27.44 - $73.84 $1.95 Million - $5.26 Million	71,195 Added 65.91%	179,208 $5.65 Million
Q4 2019 Feb 10, 2020	BUY	$35.4 - $59.82 $2.95 Million - $4.99 Million	83,406 Added 338.95%	108,013 $6.44 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $258,352 - $356,237	-7,495 Reduced 23.35%	24,607 $903,000
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $966,730 - $1.26 Million	24,108 Added 301.58%	32,102 $1.49 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $132,924 - $177,530	-3,314 Reduced 29.31%	7,994 $321,000
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $100,982 - $161,370	2,730 Added 31.83%	11,308 $520,000
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $101,483 - $128,062	2,491 Added 40.92%	8,578 $381,000
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $712,886 - $1.5 Million	-19,693 Reduced 76.39%	6,087 $239,000
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $2.63 Million - $3.22 Million	-39,917 Reduced 60.76%	25,780 $1.86 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $2.79 Million - $4.33 Million	64,158 Added 4168.81%	65,697 $4.33 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $67,408 - $81,213	1,539	1,539 $77,000

Others Institutions Holding ESPR

# of Institutions

198

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $142M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account